Published in Proteins on December 06, 2010
Structural basis for activation of calcineurin by calmodulin. J Mol Biol (2011) 0.92
A calcineurin docking motif (LXVP) in dynamin-related protein 1 contributes to mitochondrial fragmentation and ischemic neuronal injury. J Biol Chem (2013) 0.88
Modulation of calmodulin lobes by different targets: an allosteric model with hemiconcerted conformational transitions. PLoS Comput Biol (2015) 0.82
Thermodynamic linkage between calmodulin domains binding calcium and contiguous sites in the C-terminal tail of Ca(V)1.2. Biophys Chem (2011) 0.82
Calcium-dependent energetics of calmodulin domain interactions with regulatory regions of the Ryanodine Receptor Type 1 (RyR1). Biophys Chem (2014) 0.77
The Neuronal Calcium Sensor protein Acrocalcin: a potential target of calmodulin regulation during development in the coral Acropora millepora. PLoS One (2012) 0.77
Modelling intracellular competition for calcium: kinetic and thermodynamic control of different molecular modes of signal decoding. Sci Rep (2016) 0.76
Mechanisms of regulation of olfactory transduction and adaptation in the olfactory cilium. PLoS One (2014) 0.76
Modeling intracellular signaling underlying striatal function in health and disease. Prog Mol Biol Transl Sci (2014) 0.75
Calcineurin in a Crowded World. Biochemistry (2016) 0.75
Opposing Intermolecular Tuning of Ca(2+) Affinity for Calmodulin by Neurogranin and CaMKII Peptides. Biophys J (2017) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42
Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J (2000) 21.93
Ultraviolet absorption spectra of proteins and amino acids. Adv Protein Chem (1952) 9.33
Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science (1992) 6.16
Automated analysis of interatomic contacts in proteins. Bioinformatics (1999) 5.60
Calcineurin: form and function. Physiol Rev (2000) 5.26
Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science (1992) 4.89
Calmodulin: a prototypical calcium sensor. Trends Cell Biol (2000) 4.67
Sequence motifs for calmodulin recognition. FASEB J (1997) 4.38
Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry (1992) 4.25
Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J (2006) 4.06
Calmodulin in action: diversity in target recognition and activation mechanisms. Cell (2002) 3.77
Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science (1993) 3.75
Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature (2002) 3.67
Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J (1997) 3.67
Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature (2001) 3.67
Multidimensional heteronuclear nuclear magnetic resonance of proteins. Methods Enzymol (1994) 3.45
Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature (1995) 3.36
Molecular and structural basis of target recognition by calmodulin. Annu Rev Biophys Biomol Struct (1995) 3.31
Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron (2003) 3.22
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. Biochemistry (1978) 2.89
Discovery of a Ca2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett (1982) 2.75
Calmodulin as an ion channel subunit. Annu Rev Physiol (2002) 2.59
Calcineurin signaling in Saccharomyces cerevisiae: how yeast go crazy in response to stress. Biochem Biophys Res Commun (2003) 2.43
Calcineurin. Adv Enzymol Relat Areas Mol Biol (1988) 2.43
Apocalmodulin. Physiol Rev (1999) 2.30
Bacterial expression and characterization of proteins derived from the chicken calmodulin cDNA and a calmodulin processed gene. J Biol Chem (1985) 2.20
Positive cooperative binding of calcium to bovine brain calmodulin. Biochemistry (1980) 2.08
Identification of an autoinhibitory domain in calcineurin. J Biol Chem (1990) 1.99
Mechanism of local and global Ca2+ sensing by calmodulin in complex with a Ca2+ channel. Cell (2008) 1.95
Functional domain structure of calcineurin A: mapping by limited proteolysis. Biochemistry (1989) 1.86
Novel aspects of calmodulin target recognition and activation. Eur J Biochem (2003) 1.81
Intermolecular tuning of calmodulin by target peptides and proteins: differential effects on Ca2+ binding and implications for kinase activation. Protein Sci (1997) 1.63
Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes. Biophys J (2008) 1.61
Coping with stress: calmodulin and calcineurin in model and pathogenic fungi. Biochem Biophys Res Commun (2003) 1.61
Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality. Proc Natl Acad Sci U S A (2006) 1.54
Calmodulin is a limiting factor in the cell. Trends Cardiovasc Med (2002) 1.51
Quantitative determinations of calmodulin in the supernatant and particulate fractions of mammalian tissues. J Biochem (1982) 1.49
Calcium binding to calmodulin mutants monitored by domain-specific intrinsic phenylalanine and tyrosine fluorescence. Biophys J (2002) 1.44
Calcium-dependent regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a common molecular switch. Proc Natl Acad Sci U S A (2006) 1.36
NMR evidence for similarities between the DNA-binding regions of Drosophila melanogaster heat shock factor and the helix-turn-helix and HNF-3/forkhead families of transcription factors. Biochemistry (1994) 1.35
Calcium regulation of calcineurin phosphatase activity by its B subunit and calmodulin. Role of the autoinhibitory domain. J Biol Chem (1995) 1.33
Monitoring the total available calmodulin concentration in intact cells over the physiological range in free Ca2+. Cell Calcium (2004) 1.31
Intracellular coupling via limiting calmodulin. J Biol Chem (2003) 1.30
Interactions between domains of apo calmodulin alter calcium binding and stability. Biochemistry (1998) 1.28
Backbone dynamics of the Bacillus subtilis glucose permease IIA domain determined from 15N NMR relaxation measurements. Biochemistry (1992) 1.26
A direct test of the reductionist approach to structural studies of calmodulin activity: relevance of peptide models of target proteins. J Biol Chem (2002) 1.25
Calmodulin binding by calcineurin. Ligand-induced renaturation of protein immobilized on nitrocellulose. J Biol Chem (1987) 1.22
Free and bound intracellular calmodulin measurements in cardiac myocytes. Cell Calcium (2006) 1.21
Protein-peptide interaction studies demonstrate the versatility of calmodulin target protein binding. Protein Pept Lett (2006) 1.17
Quantitative endoproteinase GluC footprinting of cooperative Ca2+ binding to calmodulin: proteolytic susceptibility of E31 and E87 indicates interdomain interactions. Biochemistry (1995) 1.15
The NMDA receptor NR1 C1 region bound to calmodulin: structural insights into functional differences between homologous domains. Structure (2007) 1.13
Kinetics of calmodulin binding to calcineurin. Biochem Biophys Res Commun (2005) 1.12
Differential integration of Ca2+-calmodulin signal in intact ventricular myocytes at low and high affinity Ca2+-calmodulin targets. J Biol Chem (2008) 1.06
Calcium binding decreases the stokes radius of calmodulin and mutants R74A, R90A, and R90G. Biophys J (1996) 1.01
Backbone dynamics of the C-terminal domain of Escherichia coli topoisomerase I in the absence and presence of single-stranded DNA. Biochemistry (1996) 1.00
The neuronal voltage-dependent sodium channel type II IQ motif lowers the calcium affinity of the C-domain of calmodulin. Biochemistry (2007) 1.00
Calcium-induced interactions of calmodulin domains revealed by quantitative thrombin footprinting of Arg37 and Arg106. Biochemistry (1996) 0.98
Calcium-induced conformational switching of Paramecium calmodulin provides evidence for domain coupling. Biochemistry (2002) 0.97
The complex structure of calmodulin bound to a calcineurin peptide. Proteins (2008) 0.96
Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode. Biochemistry (2006) 0.94
Regulation of calcineurin phosphatase activity by its autoinhibitory domain. Arch Biochem Biophys (1999) 0.93
Interdomain cooperativity of calmodulin bound to melittin preferentially increases calcium affinity of sites I and II. Proteins (2008) 0.90
Phenylalanine fluorescence studies of calcium binding to N-domain fragments of Paramecium calmodulin mutants show increased calcium affinity correlates with increased disorder. Protein Sci (2001) 0.90
Characterization of the Ca2+ -dependent and -independent interactions between calmodulin and its binding domain of inducible nitric oxide synthase. FEBS Lett (1998) 0.88
Thermodynamics of calmodulin trapping by Ca2+/calmodulin-dependent protein kinase II: subpicomolar Kd determined using competition titration calorimetry. Biochemistry (2007) 0.88
Energetics of calmodulin domain interactions with the calmodulin binding domain of CaMKII. Proteins (2009) 0.86
The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding. J Biol Chem (2008) 0.85
Domain swapping and different oligomeric States for the complex between calmodulin and the calmodulin-binding domain of calcineurin a. PLoS One (2009) 0.85
A renewed model of CNA regulation involving its C-terminal regulatory domain and CaM. Biochemistry (2008) 0.84
Proteolytic footprinting titrations for estimating ligand-binding constants and detecting pathways of conformational switching of calmodulin. Methods Enzymol (2000) 0.84
Paramecium calmodulin mutants defective in ion channel regulation can bind calcium and undergo calcium-induced conformational switching. Biochemistry (2000) 0.82
Paramecium calmodulin mutants defective in ion channel regulation associate with melittin in the absence of calcium but require it for tertiary collapse. Biochemistry (2001) 0.79
Protein phosphatase 2B (PP2B, calcineurin) in Paramecium: partial characterization reveals that two members of the unusually large catalytic subunit family have distinct roles in calcium-dependent processes. Eukaryot Cell (2010) 0.78
Activation of Bordetella pertussis adenylate cyclase by the carboxyl-terminal tryptic fragment of calmodulin. Biochemistry (1986) 0.76
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A (2007) 6.44
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell (2008) 6.16
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature (2005) 5.39
O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science (2010) 2.98
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2009) 2.91
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol (2008) 2.74
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab (2010) 2.70
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med (2002) 2.29
Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science (2012) 2.22
Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab (2004) 2.19
A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes (2008) 2.09
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A (2006) 1.90
Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care (2011) 1.86
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol (2006) 1.82
Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens (2009) 1.82
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science (2013) 1.57
Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab (2003) 1.55
Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry (2004) 1.53
WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Mol Cell (2010) 1.50
Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatr Diabetes (2010) 1.48
Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab (2006) 1.47
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46
Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. J Biol Chem (2002) 1.44
Calcium binding to calmodulin mutants monitored by domain-specific intrinsic phenylalanine and tyrosine fluorescence. Biophys J (2002) 1.44
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care (2005) 1.43
Analysis of pathogenesis of juvenile new-onset diabetes. J Diabetes (2011) 1.42
SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci (2008) 1.42
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A (2002) 1.40
Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories. Clin Trials (2010) 1.33
Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes (2006) 1.30
The cavity-chaperone Skp protects its substrate from aggregation but allows independent folding of substrate domains. Proc Natl Acad Sci U S A (2009) 1.29
Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol (2011) 1.28
Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest (2002) 1.26
Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care (2011) 1.25
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care (2013) 1.23
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer (2011) 1.22
Structural and energetic determinants of apo calmodulin binding to the IQ motif of the Na(V)1.2 voltage-dependent sodium channel. Structure (2011) 1.20
Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab (2004) 1.20
GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes. Diabetes (2013) 1.19
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol (2008) 1.14
The NMDA receptor NR1 C1 region bound to calmodulin: structural insights into functional differences between homologous domains. Structure (2007) 1.13
Aging might increase myocardial ischemia / reperfusion-induced apoptosis in humans and rats. Age (Dordr) (2011) 1.13
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol (2006) 1.13
Spatial and seasonal trends in biogenic secondary organic aerosol tracers and water-soluble organic carbon in the southeastern United States. Environ Sci Technol (2008) 1.12
Discovery of a novel small molecule binding site of human survivin. Bioorg Med Chem Lett (2007) 1.11
Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc Natl Acad Sci U S A (2008) 1.10
Lobe-dependent regulation of ryanodine receptor type 1 by calmodulin. J Biol Chem (2002) 1.10
Semantic confusion regarding the development of multisensory integration: a practical solution. Eur J Neurosci (2010) 1.09
Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites. J Immunol (2008) 1.07
Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin Immunol (2002) 1.07
Incorporating cross-modal statistics in the development and maintenance of multisensory integration. J Neurosci (2012) 1.07
The yeast Alix homolog Bro1 functions as a ubiquitin receptor for protein sorting into multivesicular endosomes. Dev Cell (2013) 1.05
HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells. Nucleic Acids Res (2007) 1.05
KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther (2010) 1.02
Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract (2005) 1.02
Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes. Autoimmun Rev (2002) 1.01
HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population. Diabetes (2007) 1.00
The neuronal voltage-dependent sodium channel type II IQ motif lowers the calcium affinity of the C-domain of calmodulin. Biochemistry (2007) 1.00
An interdomain linker increases the thermostability and decreases the calcium affinity of the calmodulin N-domain. Biochemistry (2002) 0.99
Role of autoantibodies in type 1 diabetes. Front Biosci (2007) 0.99
O-antigen and core carbohydrate of Vibrio fischeri lipopolysaccharide: composition and analysis of their role in Euprymna scolopes light organ colonization. J Biol Chem (2012) 0.98
Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS One (2013) 0.98
Calcium-induced conformational switching of Paramecium calmodulin provides evidence for domain coupling. Biochemistry (2002) 0.97
Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents. BMC Public Health (2012) 0.97
Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. Diabetes Technol Ther (2015) 0.97
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab (2006) 0.97
Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med (2013) 0.96
Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. J Nutr (2010) 0.96
Comparison of insulin autoantibody: polyethylene glycol and micro-IAA 1-day and 7-day assays. Diabetes Metab Res Rev (2009) 0.96
Fluorescent PNA probes as hybridization labels for biological RNA. Biochemistry (2006) 0.95
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell (2012) 0.95
Standardization of Gene Expression Quantification by Absolute Real-Time qRT-PCR System Using a Single Standard for Marker and Reference Genes. Biomark Insights (2010) 0.94
Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation. J Am Soc Nephrol (2013) 0.94
Displacement of alpha-actinin from the NMDA receptor NR1 C0 domain By Ca2+/calmodulin promotes CaMKII binding. Biochemistry (2007) 0.94
Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol (2003) 0.93
Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus. J Mol Biol (2007) 0.91
Azide and Tween-20 reduce binding to autoantibody epitopes of islet antigen-2; implications for assay performance and reproducibility. J Immunol Methods (2009) 0.91
Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab (2009) 0.91
Murine high specificity/sensitivity competitive europium insulin autoantibody assay. Diabetes Technol Ther (2009) 0.90
Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes. PLoS One (2013) 0.90
Early continuous white noise exposure alters auditory spatial sensitivity and expression of GAD65 and GABAA receptor subunits in rat auditory cortex. Cereb Cortex (2009) 0.90
Interdomain cooperativity of calmodulin bound to melittin preferentially increases calcium affinity of sites I and II. Proteins (2008) 0.90
Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats. Hypertens Res (2013) 0.90
Dietary fat, fatty acid saturation and mitochondrial bioenergetics. J Bioenerg Biomembr (2014) 0.89
Theoretical prediction and experimental realization of new stable inorganic materials using the inverse design approach. J Am Chem Soc (2013) 0.89
Basic interdomain boundary residues in calmodulin decrease calcium affinity of sites I and II by stabilizing helix-helix interactions. Proteins (2003) 0.89
Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Biochemistry (2009) 0.89
Establishment of prognostic models for astrocytic and oligodendroglial brain tumors with standardized quantification of marker gene expression and clinical variables. Biomark Insights (2010) 0.89
Early auditory enrichment with music enhances auditory discrimination learning and alters NR2B protein expression in rat auditory cortex. Behav Brain Res (2008) 0.89
Apo-calmodulin binds with its C-terminal domain to the N-methyl-D-aspartate receptor NR1 C0 region. J Biol Chem (2003) 0.88
Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun (2005) 0.87
Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. PLoS One (2013) 0.87
Ubiquitin regulates caspase recruitment domain-mediated signaling by nucleotide-binding oligomerization domain-containing proteins NOD1 and NOD2. J Biol Chem (2013) 0.87
Energetics of calmodulin domain interactions with the calmodulin binding domain of CaMKII. Proteins (2009) 0.86
Efficient and precise measurement of H(alpha)-C(alpha), C(alpha)-C', C(alpha)-C(beta) and H(N)-N residual dipolar couplings from 2D H(N)-N correlation spectra. J Biomol NMR (2005) 0.86
Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp (2008) 0.86
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes. Proc Natl Acad Sci U S A (2014) 0.86